Inflammogenesis of secondary spinal cord injury

Frontiers in Cellular Neuroscience

Volumn 10, Issue APR, 2016, Pages

  Anwar, M Akhtar ^a   Al Shehabi, Tuqa S ^b   Eid, Ali H ^a,c  

^a Qatar University ^*  (Qatar)

^b QATAR UNIVERSITY   (Qatar)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Glia; Inflammation; Ischemia reperfusion injury (IRI); Leukocytes; Reactive oxygen species (ROS); Spinal cord injury (SCI); Therapeutics

Indexed keywords

COMPLEMENT COMPONENT C3A; CYTOKINE; ERYTHROPOIETIN; FIBRINOGEN; IBUDILAST; MINOCYCLINE; MYELIN; NEUROTOXIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRIC OXIDE; RILUZOLE;

APOPTOSIS; ASTROCYTE; BLOOD VESSEL PERMEABILITY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DAMAGE; CELL THERAPY; COMPLEMENT SYSTEM; COMPRESSION; CONTUSION; DISEASE MODEL; EDEMA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXERCISE; GANGRENE; HEMODYNAMIC PARAMETERS; HEMODYNAMIC STRESS; HOMEOSTASIS; HUMAN; HYPERTHERMIA; MACROPHAGE; MICROGLIA; MULTICENTER STUDY (TOPIC); NERVE CONDUCTION DISORDER; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SPINAL CORD INJURY; THROMBOSIS; VASOSPASM;

EID: 84963748443     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2016.00098     Document Type: Review

References (244)

1. Adams, D. H., and Nash, G. B. (1996). Disturbance of leucocyte circulation and adhesion to the endothelium as factors in circulatory pathology. Br. J. Anaesth. 77, 17-31. doi: 10.1093/bja/77.1.17
2. Akhtar, A. Z., Pippin, J. J., and Sandusky, C. B. (2008). Animal models in spinal cord injury: a review. Rev. Neurosci. 19, 47-60. doi: 10.1515/revneuro.2008.19.1.47
3. Alawieh, A., Elvington, A., and Tomlinson, S. (2015). Complement in the homeostatic and ischemic brain. Front. Immunol. 6:417. doi: 10.3389/fimmu.2015.00417
4. Al Dera, H., and Brock, J. A. (2015). Spinal Cord injury increases the reactivity of rat tail artery to angiotensin II. Front. Neurosci. 8:435. doi: 10.3389/fnins.2014.00435
5. Al Disi, S. S., Anwar, M. A., and Eid, A. H. (2015). Anti-hypertensive herbs and their mechanisms of action: part I. Front. Pharmacol. 6:323. doi: 10.3389/fphar.2015.00323
6. Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., and Tenner, A. J. (2008). The complement cascade: yin-yang in neuroinflammation-neuro-protection and -degeneration. J. Neurochem. 107, 1169-1187. doi: 10.1111/j.1471-4159.2008.05668.x
7. All, A. H., Gharibani, P., Gupta, S., Bazley, F. A., Pashai, N., Chou, B.-K., et al. (2015). Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. PLoS One 10:e0116933. doi: 10.1371/journal.pone.0116933
8. Allison, D. J., and Ditor, D. S. (2015). Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord 53, 14-18. doi: 10.1038/sc.2014.184
9. Anwar, M. A., Al Disi, S., and Eid, A. (2016a). Anti-Hypertensive herbs and their mechanisms of action: part II. Front. Pharmacol. 7:50. doi: 10.3389/fphar.2016.00050
10. Anwar, M. A., Saleh, A. I., Al Olabi, R., Al Shehabi, T. S., and Eid, A. H. (2016b). Glucocorticoid-induced fetal origins of adult hypertension: association with epigenetic events. Vascul. Pharmacol. doi: 10.1016/j.vph.2016.02.002 [Epub ahead of print].
11. Anwar, M. A., and Rampling, M. W. (2003). Abnormal hemorheological properties in patients with compensated and decompensated hepatic cirrhosis. Clin. Hemorheol. Microcirc. 29, 95-101.
12. Anwar, M. A., Rampling, M. W., Bignall, S., and Rivers, R. P. (1994). The variation with gestational age of the rheological properties of the blood of the new-born. Br. J. Haematol. 86, 163-168. doi: 10.1111/j.1365-2141.1994.tb03268.x
13. Anwar, M. A., Schwab, M., Poston, L., and Nathanielsz, P. W. (1999). Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus.Am. J. Physiol. 276, H1137-H1143.
14. Asano, T. (1980). Current trend in the research of cerebral microcirculation (author's transl). Kokyu To Junkan 28, 339-345.
15. Ayala, A., Muñoz, M. F., and Argüelles, S. (2014). Lipid peroxidation: production, metabolism and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.Oxid. Med. Cell. Longev. 2014:360438. doi: 10.1155/2014/360438
16. Azevedo, F. A. C., Carvalho, L. R. B., Grinberg, L. T., Farfel, J. M., Ferretti, R. E. L., Leite, R. E. P., et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 513, 532-541. doi: 10.1002/cne.21974
17. Bains, M., and Hall, E. D. (2012). Antioxidant therapies in traumatic brain and spinal cord injury. Biochim. Biophys. Acta 1822, 675-684. doi: 10.1016/j.bbadis.2011.10.017
18. Baldwin, S. A., Broderick, R., Osbourne, D., Waeg, G., Blades, D. A., and Scheff, S. W. (1998). The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model. J. Neurosurg.88, 874-883. doi: 10.3171/jns.1998.88.5.0874
19. Bao, F., and Liu, D. (2004). Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: Protection by a metalloporphyrin. Neuroscience 126, 285-295. doi: 10.1016/j.neuroscience.2004.03.054
20. Barger, S. W., Goodwin, M. E., Porter, M. M., and Beggs, M. L. (2007). Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 1205-1213. doi: 10.1111/j.1471-4159.2007.04487.x
21. Batchelor, P. E., Tan, S., Wills, T. E., Porritt, M. J., and Howells, D. W. (2008). Comparison of inflammation in the brain and spinal cord following mechanical injury.J. Neurotrauma 25, 1217-1225. doi: 10.1089/neu.2007.0308
22. Bauman, W. A., and Spungen, A. M. (1994). Disorders of carbohydrate and lipid-metabolism in veterans with paraplegia or quadriplegia-a model of premature aging.Metabolism 43, 749-756. doi: 10.1016/0026-0495(94)90126-0
23. Beattie, M. S. (2004). Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med. 10, 580-583. doi: 10.1016/j.molmed.2004.10.006
24. Beattie, M. S., Farooqui, A. A., and Bresnahan, J. C. (2000). Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-925. doi: 10.1089/neu.2000.17.915
25. Belch, J., McLaren, M., Hanslip, J., Hill, A., and Davidson, D. (1998). The white blood cell and plasma fibrinogen in thrombotic stroke. A significant correlation. Int. Angiol.17, 120-124.
26. Bell, J. W., Chen, D., Bahls, M., and Newcomer, S. C. (2011). Evidence for greater burden of peripheral arterial disease in lower extremity arteries of spinal cord-injured individuals. Am. J. Physiol. Heart Circ. Physiol. 301, H766-H772. doi: 10.1152/ajpheart.00507.2011
27. Bennion, D. M., Haltigan, E., Regenhardt, R. W., Steckelings, U. M., and Sumners, C. (2015). Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-mas axis in stroke. Curr. Hypertens. Rep. 17:3. doi: 10.1007/s11906-014-0512-2
28. Bhardwaj, R. D., Curtis, M. A., Spalding, K. L., Buchholz, B. A., Fink, D., Björk-Eriksson, T., et al. (2006). Neocortical neurogenesis in humans is restricted to development. Proc. Natl. Acad. Sci. U S A 103, 12564-12568. doi: 10.1073/pnas.0605177103
29. Bicknell, C. D., Riga, C. V., and Wolfe, J. H. (2009). Prevention of paraplegia during thoracoabdominal aortic aneurysm repair. Eur. J. Vasc. Endovasc. Surg. 37, 654-660. doi: 10.1016/j.ejvs.2009.02.008
30. Blair, J. A., Patzkowski, J. C., Schoenfeld, A. J., Cross Rivera, J. D., Grenier, E. S., Lehman, R. A., et al. (2012). Spinal column injuries among Americans in the global war on terrorism. J. Bone Joint Surg. Am. 94:e135. doi: 10.2106/jbjs.k.00502
31. Blight, A. R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9, S83-S91.
32. Bosmia, A. N., Hogan, E., Loukas, M., Tubbs, R. S., and Cohen-Gadol, A. A. (2015). Blood supply to the human spinal cord: part I. Anatomy and hemodynamics. Clin. Anat. 28, 52-64. doi: 10.1002/ca.22281
33. Bracken, M. B. (2001). Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine (Phila Pa 1976) 26, S47-S54. doi: 10.1097/00007632-200112151-00010
34. Bradl, M., Bauer, J., Flugel, A., Wekerle, H., and Lassmann, H. (2005). Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. Am. J. Pathol. 166, 1441-1450. doi: 10.1016/s0002-9440(10)62361-9
35. Brennan, F. H., Anderson, A. J., Taylor, S. M., Woodruff, T. M., and Ruitenberg, M. J. (2012). Complement activation in the injured central nervous system: another dual-edged sword? J. Neuroinflammation 9:137. doi: 10.1186/1742-2094-9-137
36. Brodsky, R. A., Young, N. S., Antonioli, E., Risitano, A. M., Schrezenmeier, H., Schubert, J., et al. (2008). Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.Blood 111, 1840-1847. doi: 10.1182/blood-2007-06-094136
37. Brown, B. N., Sicari, B. M., and Badylak, S. F. (2014). Rethinking regenerative medicine: a macrophage-centered approach. Front. Immunol. 5:510. doi: 10.3389/fimmu.2014.00510
38. Casha, S., Zygun, D., McGowan, M. D., Bains, I., Yong, V. W., and Hurlbert, R. J. (2012). Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 135, 1224-1236. doi: 10.1093/brain/aws072
39. Chen, J., Yang, Z., and Zhang, X. (2015). Carbamylated erythropoietin: a prospective drug candidate for neuroprotection. Biochem. Insights 8, 25-29. doi: 10.4137/BCI.s30753
40. Cheriyan, T., Ryan, D. J., Weinreb, J. H., Cheriyan, J., Paul, J. C., Lafage, V., et al. (2014). Spinal cord injury models: a review. Spinal Cord 52, 588-595. doi: 10.1038/sc.2014.91
41. Cherry, J. D., Olschowka, J. A., and O'Banion, M. K. (2014). Neuroinflammation and M2 microglia: the good, the bad and the inflamed. J. Neuroinflammation 11:98. doi: 10.1186/1742-2094-11-98
42. Choo, A. M., Liu, J., Dvorak, M., Tetzlaff, W., and Oxland, T. R. (2008). Secondary pathology following contusion, dislocation and distraction spinal cord injuries. Exp. Neurol. 212, 490-506. doi: 10.1016/j.expneurol.2008.04.038
43. Choo, A. M., Liu, J., Lam, C. K., Dvorak, M., Tetzlaff, W., and Oxland, T. R. (2007). Contusion, dislocation and distraction: primary hemorrhage and membrane permeability in distinct mechanisms of spinal cord injury. J. Neurosurg. Spine 6, 255-266. doi: 10.3171/spi.2007.6.3.255
44. Choo, A. M.-T., Liu, J., Liu, Z., Dvorak, M., Tetzlaff, W., and Oxland, T. R. (2009). Modeling spinal cord contusion, dislocation and distraction: characterization of vertebral clamps, injury severities and node of Ranvier deformations. J. Neurosci. Methods 181, 6-17. doi: 10.1016/j.jneumeth.2009.04.007
45. Chow, D. S. L., Teng, Y., Toups, E. G., Aarabi, B., Harrop, J. S., Shaffrey, C. I., et al. (2012). Pharmacology of riluzole in acute spinal cord injury. J. Neurosurg. Spine 17, 129-140. doi: 10.3171/2012.5.AOSPINE12112
46. Clausen, F., Marklund, N., Lewén, A., Enblad, P., Basu, S., and Hillered, L. (2012). Interstitial F-2-isoprostane 8-Iso-PGF(2α) as a biomarker of oxidative stress after severe human traumatic brain injury. J. Neurotrauma 29, 766-775. doi: 10.1089/neu.2011.1754
47. Constantini, S., and Young, W. (1994). The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80, 97-111. doi: 10.3171/jns.1994.80.1.0097
48. Conti, A., Miscusi, M., Cardali, S., Germanò, A., Suzuki, H., Cuzzocrea, S., et al. (2007). Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 54, 205-218. doi: 10.1016/j.brainresrev.2007.01.013
49. Cray, C., Zaias, J., and Altman, N. H. (2009). Acute phase response in animals: a review. Comp. Med. 59, 517-526.
50. Criqui, M. H., Langer, R. D., Fronek, A., Feigelson, H. S., Klauber, M. R., McCann, T. J., et al. (1992). Mortality over a period of 10 years in patients with peripheral arterial-disease. N Engl. J. Med. 326, 381-386. doi: 10.1056/nejm199202063260605
51. D'Autreaux, B., and Toledano, M. B. (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813-824. doi: 10.1038/nrm2256
52. Davalos, D., Ryu, J. K., Merlini, M., Baeten, K. M., Le Moan, N., Petersen, M. A., et al. (2012). Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 3:1227. doi: 10.1038/ncomms2230
53. David, S., Zarruk, J. G., and Ghasemlou, N. (2012). Inflammatory pathways in spinal cord injury. Int. Rev. Neurobiol. 106, 127-152. doi: 10.1016/B978-0-12-407178-0.00006-5
54. Deitrick, G., Charalel, J., Bauman, W., and Tuckman, J. (2007). Reduced arterial circulation to the legs in spinal cord injury as a cause of skin breakdown lesions.Angiology 58, 175-184. doi: 10.1177/0003319707300353
55. Dietrich, W. D. (2009). Therapeutic hypothermia for spinal cord injury. Crit. Care Med. 37, S238-S242. doi: 10.1097/CCM.0b013e3181aa5d85
56. Dumont, R. J., Okonkwo, D. O., Verma, S., Hurlbert, R. J., Boulos, P. T., Ellegala, D. B., et al. (2001). Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. 24, 254-264. doi: 10.1097/00002826-200109000-00002
57. Durafourt, B. A., Moore, C. S., Zammit, D. A., Johnson, T. A., Zaguia, F., Guiot, M. C., et al. (2012). Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60, 717-727. doi: 10.1002/glia.22298
58. Dusart, I., and Schwab, M. E. (1994). Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6, 712-724. doi: 10.1111/j.1460-9568.1994.tb00983.x
59. El Waly, B., Macchi, M., Cayre, M., and Durbec, P. (2014). Oligodendrogenesis in the normal and pathological central nervous system. Front. Neurosci. 8:145. doi: 10.3389/fnins.2014.00145
60. Ellis, E. M. (2007). Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol. Ther. 115, 13-24. doi: 10.1016/j.pharmthera.2007.03.015
61. Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., and Adamson, J. W. (1987). Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N. Engl. J. Med.316, 73-78. doi: 10.1056/NEJM198701083160203
62. Fassbender, J. M., Saraswat-Ohri, S., Myers, S. A., Gruenthal, M. J., Benton, R. L., and Whittemore, S. R. (2012). Deletion of endoplasmic reticulum stress-induced CHOP protects microvasculature post-spinal cord injury. Curr. Neurovasc. Res. 9, 274-281. doi: 10.2174/156720212803530627
63. Fassbender, J. M., Whittemore, S. R., and Hagg, T. (2011). Targeting microvasculature for neuroprotection after SCI. Neurotherapeutics 8, 240-251. doi: 10.1007/s13311-011-0029-1
64. Fehlings, M. G., Nakashima, H., Nagoshi, N., Chow, D. S. L., Grossman, R. G., and Kopjar, B. (2016). Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord 54, 8-15. doi: 10.1038/sc.2015.95
65. Félétou, M., and Vanhoutte, P. M. (2006). Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler. Thromb. Vasc. Biol. 26, 1215-1225. doi: 10.1161/01.atv.0000217611.81085.c5
66. Ferreira, A. C., Dá Mesquita, S., Sousa, J. C., Correia-Neves, M., Sousa, N., Palha, J. A., et al. (2015). From the periphery to the brain: Lipocalin-2, a friend or foe? Prog. Neurobiol. 131, 120-136. doi: 10.1016/j.pneurobio.2015.06.005
67. Festoff, B. W., Ameenuddin, S., Arnold, P. M., Wong, A., Santacruz, K. S., and Citron, B. A. (2006). Minocycline neuroprotects, reduces microgliosis and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 97, 1314-1326. doi: 10.1111/j.1471-4159.2006.03799.x
68. Fleming, J. C., Norenberg, M. D., Ramsay, D. A., Dekaban, G. A., Marcillo, A. E., Saenz, A. D., et al. (2006). The cellular inflammatory response in human spinal cords after injury. Brain 129, 3249-3269. doi: 10.1093/brain/awl296
69. Fridkis-Hareli, M., Storek, M., Mazsaroff, I., Risitano, A. M., Lundberg, A. S., Horvath, C. J., et al. (2011). Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood 118, 4705-4713. doi: 10.1182/blood-2011-06-359646
70. Frisbie, J. H. (2006). Fibrinogen metabolism in patients with spinal cord injury. J. Spinal Cord Med. 29, 507-510.
71. Galvan, M. D., Luchetti, S., Burgos, A. M., Nguyen, H. X., Hooshmand, M. J., Hamers, F. P. T., et al. (2008). Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J. Neurosci. 28, 13876-13888. doi: 10.1523/JNEUROSCI.2823-08.2008
72. Gao, X., Belmadani, S., Picchi, A., Xu, X., Potter, B. J., Tewari-Singh, N., et al. (2007). Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.Circulation 115, 245-254. doi: 10.1161/circulationaha.106.650671
73. García-Altés, A., Pérez, K., Novoa, A., Suelves, J. M., Bernabeu, M., Vidal, J., et al. (2012). Spinal cord injury and traumatic brain injury: a cost-of-illness study.Neuroepidemiology 39, 103-108. doi: 10.1159/000338297
74. Garshick, E., Kelley, A., Cohen, S. A., Garrison, A., Tun, C. G., Gagnon, D., et al. (2005). A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 43, 408-416. doi: 10.1038/sj.sc.3101729
75. Gavins, F. N., Russell, J., Senchenkova, E. L., De Almeida Paula, L., Damazo, A. S., Esmon, C. T., et al. (2011). Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S. Blood 117, 4125-4133. doi: 10.1182/blood-2010-08-301366
76. Gerber, R. T., Anwar, M. A., and Poston, L. (1998). Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br. J. Pharmacol. 125, 455-460. doi: 10.1038/sj.bjp.0702099
77. Gilbert, O., Croffoot, J. R., Taylor, A. J., Nash, M., Schomer, K., and Groah, S. (2014). Serum lipid concentrations among persons with spinal cord injury-a systematic review and meta-analysis of the literature. Atherosclerosis 232, 305-312. doi: 10.1016/j.atherosclerosis.2013.11.028
78. Gonzalez-Perez, O., and Alvarez-Buylla, A. (2011). Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res. Rev. 67, 147-156. doi: 10.1016/j.brainresrev.2011.01.001
79. Gorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., et al. (2002). Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.Proc. Natl. Acad. Sci. U S A 99, 9450-9455. doi: 10.1073/pnas.142287899
80. Granger, D. N., Rodrigues, S. F., Yildirim, A., and Senchenkova, E. Y. (2010). Microvascular responses to cardiovascular risk factors. Microcirculation 17, 192-205. doi: 10.1111/j.1549-8719.2009.00015.x
81. Groothuis, J. T., Thijssen, D. H., Rongen, G. A., Deinum, J., Danser, A. H., Geurts, A. C., et al. (2010). Angiotensin II contributes to the increased baseline leg vascular resistance in spinal cord-injured individuals. J. Hypertens. 28, 2094-2101. doi: 10.1097/HJH.0b013e32833cd2f4
82. Guízar-Sahagún, G., Velasco-Hernández, L., Martinez-Cruz, A., Castañeda-Hernández, G., Bravo, G., Rojas, G., et al. (2004). Systemic microcirculation after complete high and low thoracic spinal cord section in rats. J. Neurotrauma 21, 1614-1623. doi: 10.1089/neu.2004.21.1614
83. Hall, E. D., and Traystman, R. J. (2009). Role of animal studies in the design of clinical trials. Front. Neurol. Neurosci. 25, 10-33. doi: 10.1159/000209470
84. Hama, A., and Sagen, J. (2011). Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J. Neurotrauma 28, 127-134. doi: 10.1089/neu.2010.1539
85. Hao, J. X., and Xu, X. J. (2003). Animal models of spinal cord injury pain and their implications for pharmacological treatments. J. Rehabil. Med. 35, 81-84. doi: 10.1080/16501960310010197
86. Heiman, A., Pallottie, A., Heary, R. F., and Elkabes, S. (2014). Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord. Brain Behav. Immun. 42, 232-245. doi: 10.1016/j.bbi.2014.06.203
87. Hochmuth, R. M. (1993). Measuring the mechanical-properties of individual human blood-cells. J. Biomech. Eng. 115, 515-519. doi: 10.1115/1.2895533
88. Hollier, L. H., Money, S. R., Naslund, T. C., Proctor, C. D. Sr., Buhrman, W. C., Marino, R. J., et al. (1992). Risk of spinal cord dysfunction in patients undergoing thoracoabdominal aortic replacement. Am. J. Surg. 164, 210-213; discussion 213-214. doi: 10.1016/S0002-9610(05)81072-4
89. Hua, Y., Nakamura, T., Keep, R. F., Wu, J., Schallert, T., Hoff, J. T., et al. (2006). Long-term effects of experimental intracerebral hemorrhage: the role of iron. J. Neurosurg. 104, 305-312. doi: 10.3171/jns.2006.104.2.305
90. Huang, W., Vodovotz, Y., Kusturiss, M. B., Barclay, D., Greenwald, K., Boninger, M. L., et al. (2014). Identification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study. PM R 6, 332-341. doi: 10.1016/j.pmrj.2013.10.006
91. Huber, J. D., Hau, V. S., Mark, K. S., Brown, R. C., Campos, C. R., and Davis, T. P. (2002). Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan and complete Freund's adjuvant. Eur. J. Pharmacol. 450, 297-304. doi: 10.1016/s0014-2999(02)02150-7
92. Ito, Y., Sugimoto, Y., Tomioka, M., Kai, N., and Tanaka, M. (2009). Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury? A prospective study about neurological recovery and early complications. Spine (Phila Pa 1976) 34, 2121-2124. doi: 10.1097/BRS.0b013e3181b613c7
93. Jang, E., Lee, S., Kim, J.-H., Kim, J.-H., Seo, J.-W., Lee, W.-H., et al. (2013). Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 27, 1176-1190. doi: 10.1096/fj.12-222257
94. Janssen, B. J. C., Halff, E. F., Lambris, J. D., and Gros, P. (2007). Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition. J. Biol. Chem. 282, 29241-29247. doi: 10.1074/jbc.m704587200
95. Jelkmann, W. (2011). Regulation of erythropoietin production. J. Physiol. 589, 1251-1258. doi: 10.1113/jphysiol.2010.195057
96. Jennewein, C., Tran, N., Paulus, P., Ellinghaus, P., Eble, J. A., and Zacharowski, K. (2011). Novel aspects of fibrin(ogen) fragments during inflammation. Mol. Med. 17, 568-573. doi: 10.2119/molmed.2010.00146
97. Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., et al. (2015). Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci. Biobehav. Rev.49, 135-156. doi: 10.1016/j.neubiorev.2014.12.006
98. Johnstone, J. T., Morton, P. D., Jayakumar, A. R., Johnstone, A. L., Gao, H., Bracchi-Ricard, V., et al. (2013). Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma. PLoS One 8:e80975. doi: 10.1371/journal.pone.0080975
99. Jokiranta, T. S., Hellwage, J., Koistinen, V., Zipfel, P. F., and Meri, S. (2000). Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275, 27657-27662. doi: 10.1074/jbc.m002903200
100. Józsi, M., Tortajada, A., Uzonyi, B., Goicoechea de Jorge, E., and Rodriguez de Córdoba, S. (2015). Factor H-related proteins determine complement-activating surfaces. Trends Immunol. 36, 374-384. doi: 10.1016/j.it.2015.04.008
101. Julian, L., and Olson, M. F. (2014). Rho-associated coiled-coil containing kinases (ROCK): structure, regulation and functions. Small GTPases 5:e29846. doi: 10.4161/sgtp.29846
102. Jung, S. Y., Kim, D. Y., Yune, T. Y., Shin, D. H., Baek, S. B., and Kim, C. J. (2014). Treadmill exercise reduces spinal cord injury-induced apoptosis by activating the PI3K/Akt pathway in rats. Exp. Ther. Med. 7, 587-593. doi: 10.3892/etm.2013.1451
103. Kamath, S., and Lip, G. Y. H. (2003). Fibrinogen: biochemistry, epidemiology and determinants. QJM 96, 711-729. doi: 10.1093/qjmed/hcg129
104. Kato, M., Motoki, M., Isaji, T., Suzuki, T., Kawai, Y., and Ohkubo, N. (2015). Spinal cord injury after endovascular treatment for thoracoabdominal aneurysm or dissection. Eur. J. Cardiothorac. Surg. 48, 571-577. doi: 10.1093/ejcts/ezu497
105. Kessler, P., Popp, R., Busse, R., and Schini-Kerth, V. B. (1999). Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 99, 1878-1884. doi: 10.1161/01.cir.99.14.1878
106. Khan, B., Bauman, W. A., Sinha, A. K., and Kahn, N. N. (2011). Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury. Spinal Cord 49, 858-866. doi: 10.1038/sc.2011.33
107. King, V. R., Averill, S. A., Hewazy, D., Priestley, J. V., Torup, L., and Michael-Titus, A. T. (2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur. J. Neurosci. 26, 90-100. doi: 10.1111/j.1460-9568.2007.05635.x
108. Kirschenbaum, L. A., McKevitt, D., Rullan, M., Reisbeck, B., Fujii, T., and Astiz, M. E. (2004). Importance of platelets and fibrinogen in neutrophil-endothelial cell interactions in septic shock. Crit. Care Med. 32, 1904-1909. doi: 10.1097/01.ccm.0000139918.80602.57
109. Knoller, N., Auerbach, G., Fulga, V., Zelig, G., Attias, J., Bakimer, R., et al. (2005). Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J. Neurosurg. Spine 3, 173-181. doi: 10.3171/spi.2005.3.3.0173
110. Kolaczkowska, E., and Kubes, P. (2013). Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175. doi: 10.1038/nri3399
111. Krueger, H., Noonan, V. K., Trenaman, L. M., Joshi, P., and Rivers, C. S. (2013). The economic burden of traumatic spinal cord injury in Canada. Chronic Dis. Inj. Can. 33, 113-122.
112. Ledeboer, A., Hutchinson, M. R., Watkins, L. R., and Johnson, K. W. (2007). Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin. Investig. Drugs 16, 935-950. doi: 10.1517/13543784.16.7.935
113. Lee, S., Lee, J., Kim, S., Park, J.-Y., Lee, W.-H., Mori, K., et al. (2007). A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179, 3231-3241. doi: 10.4049/jimmunol.179.5.3231
114. Lee, M. Y., Myers, J., Abella, J., Froelicher, V. F., Perkash, I., and Kiratli, B. J. (2006). Homocysteine and hypertension in persons with spinal cord injury. Spinal Cord 44, 474-479. doi: 10.1038/sj.sc.3101873
115. Lee, S. M., Rosen, S., Weinstein, P., van Rooijen, N., and Noble-Haeusslein, L. J. (2011). Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J. Neurotrauma 28, 1893-1907. doi: 10.1089/neu.2011.1860
116. Lehnardt, S. (2010). Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58, 253-263. doi: 10.1002/glia.20928
117. Levi, A. D., Casella, G., Green, B. A., Dietrich, W. D., Vanni, S., Jagid, J., et al. (2010). Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. Neurosurgery 66, 670-677. doi: 10.1227/01.NEU.0000367557.77973.5F
118. Lieberman, J., Goff, D. Jr., Hammond, F., Schreiner, P., James Norton, H., Dulin, M., et al. (2014). Dietary intake relative to cardiovascular disease risk factors in individuals with chronic spinal cord injury: a pilot study. Top. Spinal Cord Inj. Rehabil. 20, 127-136. doi: 10.1310/sci2002-127
119. Lin, C. Y., Wright, J., Bushnik, T., and Shem, K. (2011). Traumatic spinal cord injuries in horseback riding: a 35-year review. Am. J. Sports Med. 39, 2441-2446. doi: 10.1177/0363546511419280
120. Liszewski, M. K., and Atkinson, J. P. (2015). Complement regulators in human disease: lessons from modern genetics. J. Intern. Med. 277, 294-305. doi: 10.1111/joim.12338
121. Liu, D., Sybert, T. E., Qian, H., and Liu, J. (1998). Superoxide production after spinal injury detected by microperfusion of cytochrome c. Free Radic. Biol. Med. 25, 298-304. doi: 10.1016/s0891-5849(98)00055-0
122. Lo, T. P. Jr., Cho, K.-S., Garg, M. S., Lynch, M. P., Marcillo, A. E., Koivisto, D. L., et al. (2009). Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats. J. Comp. Neurol. 514, 433-448. doi: 10.1002/cne.22014
123. Lombardero, M., Kovacs, K., and Scheithauer, B. W. (2011). Erythropoietin: a hormone with multiple functions. Pathobiology 78, 41-53. doi: 10.1159/000322975
124. Lominadze, D., Dean, W. L., Tyagi, S. C., and Roberts, A. M. (2010). Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol. (Oxf.) 198, 1-13. doi: 10.1111/j.1748-1716.2009.02037.x
125. Lord-Fontaine, S., Yang, F., Diep, Q., Dergham, P., Munzer, S., Tremblay, P., et al. (2008). Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J. Neurotrauma 25, 1309-1322. doi: 10.1089/neu.2008.0613
126. Losey, P., and Anthony, D. C. (2014). Impact of vasculature damage on the outcome of spinal cord injury: a novel collagenase-induced model may give new insights into the mechanisms involved. Neural Regen. Res. 9, 1783-1786. doi: 10.4103/1673-5374.143422
127. Losey, P., Young, C., Krimholtz, E., Bordet, R., and Anthony, D. C. (2014). The role of hemorrhage following spinal-cord injury. Brain Res. 1569, 9-18. doi: 10.1016/j.brainres.2014.04.033
128. Lubin, F. D., Gupta, S., Parrish, R. R., Grissom, N. M., and Davis, R. L. (2011). Epigenetic mechanisms: critical contributors to long-term memory formation.Neuroscientist 17, 616-632. doi: 10.1177/1073858411386967
129. Luedtke, K., Bouchard, S. M., Woller, S. A., Funk, M. K., Aceves, M., and Hook, M. A. (2014). Assessment of depression in a rodent model of spinal cord injury. J. Neurotrauma 31, 1107-1121. doi: 10.1089/neu.2013.3204
130. Luo, J., Uchida, K., and Shi, R. Y. (2005). Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem. Res. 30, 291-295. doi: 10.1007/s11064-005-2602-7
131. Maggio, D. M., Chatzipanteli, K., Masters, N., Patel, S. P., Dietrich, W. D., and Pearse, D. D. (2012). Acute molecular perturbation of inducible nitric oxide synthase with an antisense approach enhances neuronal preservation and functional recovery after contusive spinal cord injury. J. Neurotrauma 29, 2244-2249. doi: 10.1089/neu.2012.2371
132. Maldonado Bouchard, S., and Hook, M. A. (2014). Psychological stress as a modulator of functional recovery following spinal cord injury. Front. Neurol. 5:44. doi: 10.3389/fneur.2014.00044
133. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization.Trends Immunol. 25, 677-686. doi: 10.1016/j.it.2004.09.015
134. Marsala, J., Orendácová, J., Lukácová, N., and Vanický, I. (2007). Traumatic injury of the spinal cord and nitric oxide. Prog. Brain Res. 161, 171-183. doi: 10.1016/s0079-6123(06)61011-x
135. Martirosyan, N. L., Feuerstein, J. S., Theodore, N., Cavalcanti, D. D., Spetzler, R. F., and Preul, M. C. (2011). Blood supply and vascular reactivity of the spinal cord under normal and pathological conditions. J. Neurosurg. Spine 15, 238-251. doi: 10.3171/2011.4.SPINE10543
136. Mastellos, D. C., Yancopoulou, D., Kokkinos, P., Huber-Lang, M., Hajishengallis, G., Biglarnia, A. R., et al. (2015). Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur. J. Clin. Invest. 45, 423-440. doi: 10.1111/eci.12419
137. Matsui, T., Svensson, C. I., Hirata, Y., Mizobata, K., Hua, X.-Y., and Yaksh, T. L. (2010). Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth. Analg. 111, 554-560. doi: 10.1213/ANE.0b013e3181e3a2a2
138. Mautes, A. E., Weinzierl, M. R., Donovan, F., and Noble, L. J. (2000). Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 80, 673-687.
139. McHedlishvili, G., Gobejishvili, L., Mamaladze, A., Momtselidze, N., and Varazashvili, M. (1999). Microcirculatory stasis induced by hemorheological disorders: further evidence. Microcirculation 6, 97-106. doi: 10.1080/713773944
140. McKerracher, L., and Anderson, K. D. (2013). Analysis of recruitment and outcomes in the phase I/IIa cethrin clinical trial for acute spinal cord injury. J. Neurotrauma 30, 1795-1804. doi: 10.1089/neu.2013.2909
141. McTigue, D. M., and Tripathi, R. B. (2008). The life, death and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107, 1-19. doi: 10.1111/j.1471-4159.2008.05570.x
142. Medzhitov, R. (2010). Inflammation 2010: new adventures of an old flame. Cell 140, 771-776. doi: 10.1016/j.cell.2010.03.006
143. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015). Complement system part I-molecular mechanisms of activation and regulation. Front. Immunol. 6:262. doi: 10.3389/fimmu.2015.00262
144. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
145. Mizuno, T., Kurotani, T., Komatsu, Y., Kawanokuchi, J., Kato, H., Mitsuma, N., et al. (2004). Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46, 404-411. doi: 10.1016/j.neuropharm.2003.09.009
146. Mofidi, A., Bader, A., and Pavlica, S. (2011). The use of erythropoietin and its derivatives to treat spinal cord injury. Mini Rev. Med. Chem. 11, 763-770. doi: 10.2174/138955711796355267
147. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
148. Mosesson, M. W. (2005). Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3, 1894-1904. doi: 10.1111/j.1538-7836.2005.01365.x
149. Mullick, A. E., McDonald, J. M., Melkonian, G., Talbot, P., Pinkerton, K. E., and Rutledge, J. C. (2002). Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am. J. Physiol. Heart Circ. Physiol. 283, H591-H597. doi: 10.1152/ajpheart.01046.2001
150. Myers, S. A., Andres, K. R., Hagg, T., and Whittemore, S. R. (2014). CD36 deletion improves recovery from spinal cord injury. Exp. Neurol. 256, 25-38. doi: 10.1016/j.expneurol.2014.03.016
151. Myers, S. A., DeVries, W. H., Andres, K. R., Gruenthal, M. J., Benton, R. L., Hoying, J. B., et al. (2011). CD47 knockout mice exhibit improved recovery from spinal cord injury. Neurobiol. Dis. 42, 21-34. doi: 10.1016/j.nbd.2010.12.010
152. Nagai, A., Nakagawa, E., Choi, H. B., Hatori, K., Kobayashi, S., and Kim, S. U. (2001). Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60, 386-392. doi: 10.1093/jnen/60.4.386
153. Neirinckx, V., Coste, C., Franzen, R., Gothot, A., Rogister, B., and Wislet, S. (2014). Neutrophil contribution to spinal cord injury and repair. J. Neuroinflammation 11:50. doi: 10.1186/s12974-014-0150-2
154. Nesathurai, S., Graham, W. A., Mansfield, K., Magill, D., Sehgal, P., Westmoreland, S. V., et al. (2006). Model of traumatic spinal cord injury in Macaca fascicularis: similarity of experimental lesions created by epidural catheter to human spinal cord injury. J. Med. Primatol. 35, 401-404. doi: 10.1111/j.1600-0684.2006.00162.x
155. Nguyen, D. H., Cho, N., Satkunendrarajah, K., Austin, J. W., Wang, J., and Fehlings, M. G. (2012). Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J. Neuroinflammation9:224. doi: 10.1186/1742-2094-9-224
156. Nout, Y. S., Rosenzweig, E. S., Brock, J. H., Strand, S. C., Moseanko, R., Hawbecker, S., et al. (2012). Animal models of neurologic disorders: a nonhuman primate model of spinal cord injury. Neurotherapeutics 9, 380-392. doi: 10.1007/s13311-012-0114-0
157. Nowakowski, R. S. (2006). Stable neuron numbers from cradle to grave. Proc. Natl. Acad. Sci. U S A 103, 12219-12220. doi: 10.1073/pnas.0605605103
158. Oliveri, R. S., Bello, S., and Biering-Sorensen, F. (2014). Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. Neurobiol. Dis. 62, 338-353. doi: 10.1016/j.nbd.2013.10.014
159. Olson, J. K., and Miller, S. D. (2004). Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916-3924. doi: 10.4049/jimmunol.173.6.3916
160. Osaka, M., Honmou, O., Murakami, T., Nonaka, T., Houkin, K., Hamada, H., et al. (2010). Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res.1343, 226-235. doi: 10.1016/j.brainres.2010.05.011
161. Pahl, M. V., Vaziri, N. D., and Gonzales, E. (1994). Coagulation profile in persons with long-standing spinal cord injury. J. Am. Paraplegia Soc. 17, 133-135.
162. Paixão, S., and Klein, R. (2010). Neuron-astrocyte communication and synaptic plasticity. Curr. Opin. Neurobiol. 20, 466-473. doi: 10.1016/j.conb.2010.04.008
163. Pan, J. Z., Ni, L., Sodhi, A., Aguanno, A., Young, W., and Hart, R. P. (2002). Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 68, 315-322. doi: 10.1002/jnr.10215
164. Pannu, R., and Singh, I. (2006). Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem. Int. 49, 170-182. doi: 10.1016/j.neuint.2006.04.010
165. Parsa, R., Andresen, P., Gillett, A., Mia, S., Zhang, X. M., Mayans, S., et al. (2012). Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61, 2881-2892. doi: 10.2337/db11-1635
166. Pearson, M. J., and Lipowsky, H. H. (2004). Effect of fibrinogen on leukocyte margination and adhesion in postcapillary venules. Microcirculation 11, 295-306. doi: 10.1080/10739680490425994
167. Perea, G., and Araque, A. (2007). Astrocytes potentiate transmitter release at single hippocampal synapses. Science 317, 1083-1086. doi: 10.1126/science.1144640
168. Peterson, S. L., and Anderson, A. J. (2014). Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment. Exp. Neurol. 258, 35-47. doi: 10.1016/j.expneurol.2014.04.028
169. Peterson, S. L., Nguyen, H. X., Mendez, O. A., and Anderson, A. J. (2015). Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. J. Neurosci. 35, 4332-4349. doi: 10.1523/JNEUROSCI.4473-12.2015
170. Pineau, I., and Lacroix, S. (2007). Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500, 267-285. doi: 10.1002/cne.21149
171. Popa, C., Popa, F., Grigorean, V. T., Onose, G., Sandu, A. M., Popescu, M., et al. (2010). Vascular dysfunctions following spinal cord injury. J. Med. Life 3, 275-285.
172. Popovich, P. G., Wei, P., and Stokes, B. T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464. doi: 10.1002/(sici)1096-9861(19970120)377:3<443::aid-cne10>3.0.co;2-s
173. Qian, H., and Liu, D. (1997). The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem. Res. 22, 1231-1236. doi: 10.1023/A:1021980929422
174. Quarrie, K. L., Cantu, R. C., and Chalmers, D. J. (2002). Rugby union injuries to the cervical spine and spinal cord. Sports Med. 32, 633-653. doi: 10.2165/00007256-200232100-00003
175. Rakic, P. (1985). Limits of neurogenesis in primates. Science 227, 1054-1056. doi: 10.1126/science.3975601
176. Rampling, M. W. (1981). The binding of fibrinogen and fibrinogen degradation products to the erythrocyte membrane and its relationship to haemorheology. Acta Biol. Med. Ger. 40, 373-378.
177. Rampling, M. W. (1998). Haemorheology and the inflammatory process. Clin. Hemorheol. Microcirc. 19, 129-132.
178. Rampling, M. W., and Challoner, T. (1983). A theoretical analysis of the effects of varying fibrinogen concentration and haematocrit on the flow characteristics of blood in cylindrical tubes. Biorheology 20, 141-152.
179. Rampling, M. W., Meiselman, H. J., Neu, B., and Baskurt, O. K. (2004). Influence of cell-specific factors on red blood cell aggregation. Biorheology 41, 91-112.
180. Rebhun, J., Madorsky, J. G., and Glovsky, M. M. (1991). Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury. Ann. Allergy 66, 335-338.
181. Rihn, J. A., Anderson, D. T., Lamb, K., Deluca, P. F., Bata, A., Marchetto, P. A., et al. (2009). Cervical spine injuries in American football. Sports Med. 39, 697-708. doi: 10.2165/11315190-000000000-00000
182. Risitano, A. M., Notaro, R., Pascariello, C., Sica, M., del Vecchio, L., Horvath, C. J., et al. (2012). The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Blood 119, 6307-6316. doi: 10.1182/blood-2011-12-398792
183. Risitano, A. M., Ricklin, D., Huang, Y., Reis, E. S., Chen, H., Ricci, P., et al. (2014). Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood 123, 2094-2101. doi: 10.1182/blood-2013-11-536573
184. Rosenzweig, E. S., and McDonald, J. W. (2004). Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr. Opin. Neurol. 17, 121-131. doi: 10.1097/00019052-200404000-00007
185. Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., and Bell, L. (2007). Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat. Biotechnol. 25, 1256-1264. doi: 10.1038/nbt1344
186. Rothwell, N., Allan, S., and Toulmond, S. (1997). The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100, 2648-2652. doi: 10.1172/jci119808
187. Rummery, N. M., Tripovic, D., McLachlan, E. M., and Brock, J. A. (2010). Sympathetic vasoconstriction is potentiated in arteries caudal but not rostral to a spinal cord transection in rats. J. Neurotrauma 27, 2077-2089. doi: 10.1089/neu.2010.1468
188. Sabapathy, V., Tharion, G., and Kumar, S. (2015). Cell therapy augments functional recovery subsequent to spinal cord injury under experimental conditions. Stem Cells Int. 2015:132172. doi: 10.1155/2015/132172
189. Saltzman, J. W., Battaglino, R. A., Salles, L., Jha, P., Sudhakar, S., Garshick, E., et al. (2013). B-cell maturation antigen, a proliferation-inducing ligand and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunity. J. Neurotrauma 30, 434-440. doi: 10.1089/neu.2012.2501
190. Sandrow-Feinberg, H. R., and Houlé, J. D. (2015). Exercise after spinal cord injury as an agent for neuroprotection, regeneration and rehabilitation. Brain Res. 1619, 12-21. doi: 10.1016/j.brainres.2015.03.052
191. Satake, K., Matsuyama, Y., Kamiya, M., Kawakami, H., Iwata, H., Adachi, K., et al. (2000). Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res. Mol. Brain Res. 85, 114-122. doi: 10.1016/s0169-328x(00)00253-9
192. Schachtrup, C., Ryu, J. K., Helmrick, M. J., Vagena, E., Galanakis, D. K., Degen, J. L., et al. (2010). Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J. Neurosci. 30, 5843-5854. doi: 10.1523/JNEUROSCI.0137-10.2010
193. Schoenfeld, A. J., Laughlin, M. D., McCriskin, B. J., Bader, J. O., Waterman, B. R., and Belmont, P. J. Jr., et al. (2013). Spinal injuries in United States military personnel deployed to Iraq and Afghanistan: an epidemiological investigation involving 7877 combat casualties from 2005 to 2009. Spine 38, 1770-1778. doi: 10.1097/BRS.0b013e31829ef226
194. Schwab, M. E., and Bartholdi, D. (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319-370.
195. Sekhon, L. H., and Fehlings, M. G. (2001). Epidemiology, demographics and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 26, S2-S12. doi: 10.1097/00007632-200112151-00002
196. Selassie, A., Snipe, L., Focht, K. L., and Welldaregay, W. (2013). Baseline prevalence of heart diseases, hypertension, diabetes and obesity in persons with acute traumatic spinal cord injury: potential threats in the recovery trajectory. Top. Spinal Cord Inj. Rehabil. 19, 172-182. doi: 10.1310/sci1903-172
197. Shao, C., Roberts, K. N., Markesbery, W. R., Scheff, S. W., and Lovell, M. A. (2006). Oxidative stress in head trauma in aging. Free Radic. Biol. Med. 41, 77-85. doi: 10.1016/j.freeradbiomed.2006.03.007
198. Sharma, H. S. (2011). Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection.J. Neural Transm. (Vienna) 118, 155-176. doi: 10.1007/s00702-010-0514-4
199. Shechter, R., London, A., Varol, C., Raposo, C., Cusimano, M., Yovel, G., et al. (2009). Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6:e1000113. doi: 10.1371/journal.pmed.1000113
200. Sheng, W., Zong, Y., Mohammad, A., Ajit, D., Cui, J., Han, D., et al. (2011). Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia. J. Neuroinflammation 8:121. doi: 10.1186/1742-2094-8-121
201. Shields, D. C., Schaecher, K. E., Hogan, E. L., and Banik, N. L. (2000). Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J. Neurosci. Res. 61, 146-150. doi: 10.1002/1097-4547(20000715)61:2<146::aid-jnr5>3.0.co;2-c
202. Shimizu, H., and Yozu, R. (2011). Current strategies for spinal cord protection during thoracic and thoracoabdominal aortic aneurysm repair. Gen. Thorac. Cardiovasc. Surg. 59, 155-163. doi: 10.1007/s11748-010-0705-9
203. Shuman, S. L., Bresnahan, J. C., and Beattie, M. S. (1997). Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50, 798-808. doi: 10.1002/(sici)1097-4547(19971201)50:5<798::aid-jnr16>3.0.co;2-y
204. Silva, N. A., Sousa, N., Reis, R. L., and Salgado, A. J. (2014). From basics to clinical: a comprehensive review on spinal cord injury. Prog. Neurobiol. 114, 25-57. doi: 10.1016/j.pneurobio.2013.11.002
205. Simon, F., Scheuerle, A., Groger, M., Vcelar, B., McCook, O., Moller, P., et al. (2011). Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Med. 37, 1525-1533. doi: 10.1007/s00134-011-2303-4
206. Singh, A., Tetreault, L., Kalsi-Ryan, S., Nouri, A., and Fehlings, M. G. (2014). Global prevalence and incidence of traumatic spinal cord injury. Clin. Epidemiol. 6, 309-331. doi: 10.2147/CLEP.s68889
207. Smith, J. A., Siegel, J. H., and Siddiqi, S. Q. (2005). Spine and spinal cord injury in motor vehicle crashes: a function of change in velocity and energy dissipation on impact with respect to the direction of crash. J. Trauma 59, 117-131. doi: 10.1097/01.ta.0000171534.75347.52
208. Sng, J., and Meaney, M. J. (2009). Environmental regulation of the neural epigenome.Epigenomics 1, 131-151. doi: 10.2217/epi.09.21
209. Stahel, P. F., VanderHeiden, T., and Finn, M. A. (2012). Management strategies for acute spinal cord injury: current options and future perspectives. Curr. Opin. Crit. Care 18, 651-660. doi: 10.1097/MCC.0b013e32835a0e54
210. Stirling, D. P., Khodarahmi, K., Liu, J., McPhail, L. T., McBride, C. B., Steeves, J. D., et al. (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback and improves functional outcome after spinal cord injury. J. Neurosci.24, 2182-2190. doi: 10.1523/jneurosci.5275-03.2004
211. Stoner, L., Sabatier, M., VanhHiel, L., Groves, D., Ripley, D., Palardy, G., et al. (2006). Upper vs. lower extremity arterial function after spinal cord injury. J. Spinal Cord Med. 29, 138-146.
212. Tabata, H. (2015). Diverse subtypes of astrocytes and their development during corticogenesis. Front. Neurosci. 9:114. doi: 10.3389/fnins.2015.00114
213. Tang, Y., Li, T., Li, J., Yang, J., Liu, H., Zhang, X. J., et al. (2014). Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease. Cell Death Differ. 21, 369-380. doi: 10.1038/cdd.2013.159
214. Tardivo, V., Crobeddu, E., Pilloni, G., Fontanella, M., Spena, G., Panciani, P. P., et al. (2015). Say "no" to spinal cord injury: is nitric oxide an option for therapeutic strategies? Int. J. Neurosci. 125, 81-90. doi: 10.3109/00207454.2014.908877
215. Tator, C. H., and Koyanagi, I. (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86, 483-492. doi: 10.3171/jns.1997.86.3.0483
216. Thompson, C. D., Zurko, J. C., Hanna, B. F., Hellenbrand, D. J., and Hanna, A. (2013). The therapeutic role of interleukin-10 after spinal cord injury. J. Neurotrauma 30, 1311-1324. doi: 10.1089/neu.2012.2651
217. Toda, N., Ayajiki, K., and Okamura, T. (2009). Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol. Rev. 61, 62-97. doi: 10.1124/pr.108.000547
218. Vajapey, R., Rini, D., Walston, J., and Abadir, P. (2014). The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front. Physiol. 5:439. doi: 10.3389/fphys.2014.00439
219. Valparaiso, A. P., Vicente, D. A., Bograd, B. A., Elster, E. A., and Davis, T. A. (2015). Modeling acute traumatic injury. J. Surg. Res. 194, 220-232. doi: 10.1016/j.jss.2014.10.025
220. Varma, A. K., Das, A., Wallace, G. T., Barry, J., Vertegel, A. A., Ray, S. K., et al. (2013). Spinal cord injury: a review of current therapy, future treatments and basic science frontiers. Neurochem. Res. 38, 895-905. doi: 10.1007/s11064-013-0991-6
221. Walters, E. T. (2014). Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense. Exp. Neurol. 258, 48-61. doi: 10.1016/j.expneurol.2014.02.001
222. Watzlawick, R., Sena, E. S., Dirnagl, U., Brommer, B., Kopp, M. A., Macleod, M. R., et al. (2014). Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis.JAMA Neurol. 71, 91-99. doi: 10.1001/jamaneurol.2013.4684
223. West, C. R., Alyahya, A., Laher, I., and Krassioukov, A. (2013). Peripheral vascular function in spinal cord injury: a systematic review. Spinal Cord 51, 10-19. doi: 10.1038/sc.2012.136
224. Wilson, J. R., and Fehlings, M. G. (2014). Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy. World Neurosurg. 81, 825-829. doi: 10.1016/j.wneu.2013.01.001
225. Wilson, J. R., Forgione, N., and Fehlings, M. G. (2013). Emerging therapies for acute traumatic spinal cord injury. CMAJ 185, 485-492. doi: 10.1503/cmaj.121206
226. Wilt, T. J., Carlson, K. F., Goldish, G. D., MacDonald, R., Niewoehner, C., Rutks, I., et al. (2008). Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. Evid. Rep. Technol. Assess. (Full. Rep.) 163, 1-95.
227. Witcher, K. G., Eiferman, D. S., and Godbout, J. P. (2015). Priming the inflammatory pump of the CNS after traumatic brain injury. Trends Neurosci. 38, 609-620. doi: 10.1016/j.tins.2015.08.002
228. Woodruff, T. M., Ager, R. R., Tenner, A. J., Noakes, P. G., and Taylor, S. M. (2010). The role of the complement system and the activation fragment C5a in the central nervous system. Neuromolecular Med. 12, 179-192. doi: 10.1007/s12017-009-8085-y
229. Wu, J. C., Chen, Y. C., Liu, L., Chen, T. J., Huang, W. C., Cheng, H., et al. (2012). Increased risk of stroke after spinal cord injury: a nationwide 4-year follow-up cohort study. Neurology 78, 1051-1057. doi: 10.1212/wnl.0b013e31824e8eaa
230. Wu, X. B., Helfrich, M. H., Horton, M. A., Feigen, L. P., and Lefkowith, J. B. (1994). Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J. Clin. Invest. 94, 928-936. doi: 10.1172/jci117459
231. Wu, Y., Satkunendrarajah, K., Teng, Y., Chow, D. S. L., Buttigieg, J., and Fehlings, M. G. (2013). Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J. Neurotrauma 30, 441-452. doi: 10.1089/neu.2012.2622
232. Wu, J., Wu, Y.-Q., Ricklin, D., Janssen, B. J. C., Lambris, J. D., and Gros, P. (2009). Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10, 728-733. doi: 10.1038/ni.1755
233. Wynn, T. A., Chawla, A., and Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496, 445-455. doi: 10.1038/nature12034
234. Xiong, Y., and Hall, E. D. (2009). Pharmacological evidence for a role of peroxynitrite in the pathophysiology of spinal cord injury. Exp. Neurol. 216, 105-114. doi: 10.1016/j.expneurol.2008.11.025
235. Yang, Y., Bazhin, A. V., Werner, J., and Karakhanova, S. (2013). Reactive oxygen species in the immune system. Int. Rev. Immunol. 32, 249-270. doi: 10.3109/08830185.2012.755176
236. Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., and Giffard, R. G. (2006). Microglia potentiate damage to blood-brain barrier constituents: improvement by minocyclinein vivo and in vitro. Stroke 37, 1087-1093. doi: 10.1161/01.str.0000206281.77178.ac
237. York, E. M., Petit, A., and Roskams, A. J. (2013). Epigenetics of neural repair following spinal cord injury. Neurotherapeutics 10, 757-770. doi: 10.1007/s13311-013-0228-z
238. Yune, T. Y., Lee, J. Y., Jung, G. Y., Kim, S. J., Jiang, M. H., Kim, Y. C., et al. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 27, 7751-7761. doi: 10.1523/jneurosci.1661-07.2007
239. Zhang, B., and Gensel, J. C. (2014). Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord. Exp. Neurol. 258, 112-120. doi: 10.1016/j.expneurol.2014.04.007
240. Zhang, H., Park, Y., Wu, J., Chen, X. P., Lee, S., Yang, J., et al. (2009). Role of TNF-α in vascular dysfunction. Clin. Sci. (Lond). 116, 219-230. doi: 10.1042/CS20080196
241. Zhang, L., An, G. Y., Zhang, W. G., and Chen, K. (2012). Effects of tanshinone- II A sulfonate on expression of nuclear factor-kappaB, vascular cell adhesion molecule-1 and hemorrheology during spinal cord ischemia reperfusion injury. Zhongguo Gu Shang 25, 1016-1020.
242. Zhou, X., He, X. J., and Ren, Y. (2014). Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen. Res. 9, 1787-1795. doi: 10.4103/1673-5374.143423
243. Zhu, P., Li, J.-X., Fujino, M., Zhuang, J., and Li, X.-K. (2013). Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury. Mediators Inflamm. 2013:701970. doi: 10.1155/2013/701970
244. Zilliacus, H. (1951). Intravascular erythrocyte aggregation and the sedimentation reaction in local inflammation in the tissues. Acta Med. Scand. 140, 149-151. doi: 10.1111/j.0954-6820.1951.tb10165.x